- Clinical Expertise: Internal Medicine; Emergency Cancer-Related Care
- Languages Spoken: English
- Education: MD, The University of Texas Medical School at Houston; PhD, The University of Texas MD Anderson Cancer Center
- Residencies: Mount Sinai Medical Center
- Board Certifications: Internal Medicine
Mendes KN*, Wang GK*, Fuller GN, and Zhang W. (2010) JNK mediates insulin-like growth factor binding protein 2 (IGFBP2) / integrin a5-dependent glioma cell migration. Int J Oncol 37, 143-153. (*shared first-authorship)
Wang GK, Hu L, Fuller GN, and Zhang W. (2006) An interaction between insulin-like growth factor binding protein 2 (IGFBP2) and integrin a5 is essential for IGFBP2-induced cell mobility. J Biol Chem 281, 14085-91.
Brecht S, Carruthers VB, Ferguson DJ, Giddings OK, Wang G, Jakle U, Harper JM, Sibley LD, and Soldati D. (2001) The toxoplasma micronemal protein MIC4 is an adhesin composed of six conserved apple domains. J Biol Chem 276, 4119-27.
Marsh AE, Howe DK, Wang G, Barr BC, Cannon N, and Conrad PA. (1999) Differentiation of Neospora hughesi from Neospora caninum based on their immunodominant surface antigen, SAG1 and SRS2. Int J Parasitol 29, 1575-82.
As home to one of the world’s top cancer research centers, Memorial Sloan Kettering is typically involved in more than 900 clinical trials at a given time. Currently, clinical trials focused on the conditions I treat are enrolling new patients. If you’re interested in joining a clinical trial, click to learn about the trial’s purpose, eligibility criteria, and how to get more information.Learn more